Credit: Adrien Vaquié
Actin spheres (green) wrapped around a severed axon (red)
Injured axons instruct Schwann cells to build specialized actin spheres to break down and remove axon fragments, thereby starting the regeneration process
Damaged peripheral nerves can regenerate after an injury, for example, following a forearm fracture. Axons, the long projections of neurons that transmit stimuli or signals to other cells, are affected in the case of injury and need to regrow to recover their function. The research team led by Prof. Claire Jacob at Johannes Gutenberg University Mainz (JGU) and at the Swiss University of Fribourg investigated the details of this repair process and have demonstrated that the same mechanism could be activated in cells of the central nervous system – after a spinal cord injury, for instance. Their results have been published in the renowned journal Cell Reports.
“An injury in the peripheral nervous system quickly triggers the activation of a fascinating repair process that allows the injured nerve to regenerate and regain its function. There is no such repair process in the central nervous system, thus injuries often lead to permanent damage such as paraplegia,” explains Claire Jacob, Head of Cellular Neurobiology at JGU. Strategies to improve axon regeneration in the central nervous system must therefore be developed to enable healing.
Myelin-forming cells are key to the axon regeneration process. Many axons are ensheathed by myelin, which serves as a protective layer while also enabling fast and efficient signal transmission. “Myelin is extremely important for the function of the entire nervous system, however it also hinders the repair process in case of an injury,” adds Claire Jacob. Myelin is produced by Schwann cells in the peripheral nervous system and by oligodendrocytes in the central nervous system; this difference has a major impact on axon regeneration, because Schwann cells and oligodendrocytes respond very differently to axonal injury.
Schwann cells can do everything – they break down myelin and damaged axons
When axons of the peripheral nervous system are injured, Schwann cells rapidly induce the disintegration of the cut-out axonal segments into small fragments, which can then be digested by Schwann cells themselves or later by macrophages. This elimination of axonal debris is one of the first and critical steps of the repair process. “Schwann cells can do everything. We discovered that they not only digest myelin following injury, but they also induce the disintegration of the long axon segments that are separated from their cell bodies due to the injury,” points out Claire Jacob. In order to do that, Schwann cells form small spheres made of a protein called actin; these actin spheres exert pressure on the isolated axon segments until their disintegration into small pieces. This targeted degradation of cell debris is essential to enable the healthy part of the axon that remained attached to the neuron cell body to grow back, connect to its former target and thereby regain full functionality.
Severed axons transmit signals to Schwann cells
Of particular interest, the Jacob team found that severed axonal segments send a signal to Schwann cells that prompts them to start the actin sphere formation and axon disintegration process, an impressive and precisely coordinated form of interaction between the two cell types. If this mechanism is disrupted, axonal disintegration is slowed down and axonal fragments impair the regeneration of the affected nerve.
Manipulated oligodendrocytes can also generate actin structures
Claire Jacob’s team went on to study the central nervous system and the behavior of oligodendrocytes. “After an injury, oligodendrocytes either die or remain apparently unresponsive,” says Claire Jacob. Oligodendrocytes are not (normally) able, like Schwann cells, to form actin spheres and thus break down axon segments. One reason for this is that, unlike Schwann cells, they do not express VEGFR1, the receptor that triggers the production of actin spheres in Schwann cells. In the next step, the research team induced the expression of VEGFR1 in oligodendrocytes. This allowed oligodendrocytes to produce actin structures and disintegrate severed axonal fragments; this is an essential step to promote the regeneration of neurons in the central nervous system.
The team is currently working at identifying the molecular processes that trigger the removal of myelin at the site of injury in the central nervous system. In addition to the disposal of axonal debris, myelin removal is a second prerequisite necessary for the complete regeneration of neurons. “We have discovered a pathway that accelerates myelin degradation in the peripheral nervous system and are now trying to determine whether this can also trigger myelin removal in the central nervous system,” adds Claire Jacob, describing the results of on-going research in her lab.
Learn more: First step to induce self-repair in the central nervous system
The Latest on: Self-repair in the central nervous system
via Google News
The Latest on: Self-repair in the central nervous system
- Nervous system workings related to PTSD, other mental health disorderson July 5, 2022 at 3:38 pm
A new study measures changes in the human brain's response to a perceived threat following non-invasive stimulation of the nervous system via the vagus nerve. The results have implications for the ...
- East African newborns at increased risk for central nervous system birth defectson July 1, 2022 at 7:18 am
Newborns, whose brains, spines or spinal cords do not properly develop in utero, can be born with neural tube defects (NTD), increasing their risk of physical disabilities, intellectual impairments ...
- USPTO Issues Patent Covering Use of XPro™ for Treatment of CNS Diseaseson June 24, 2022 at 10:05 am
and treating diseases of the Central Nervous System (CNS). The patent is currently set to provide coverage through September 10, 2033, subject to a possible patent term extension if requested by the ...
- USPTO Issues Patent Covering Use of XPro™ for Treatment of CNS Diseaseson June 24, 2022 at 10:05 am
and treating diseases of the Central Nervous System (CNS). The patent is currently set to provide coverage through September 10, 2033, subject to a possible patent term extension if requested by ...
- INmune Bio receives US patent covering use of XPro for treatment of CNS diseaseson June 24, 2022 at 1:30 am
INmune Bio receives US patent covering use of XPro for treatment of CNS diseases: Boca Raton, Florida Friday, June 24, 2022, 14:00 Hrs [IST] INmune Bio, Inc., a clinical-stage imm ...
- Researchers learn that ALS may be linked to both the immune and central nervous systemson June 22, 2022 at 1:42 pm
The immune system may play a fundamental role along with the central nervous system in amyotrophic lateral sclerosis (ALS), also known as "Lou Gehrig's disease," Mount Sinai researchers report. Their ...
- The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infectionon June 22, 2022 at 5:52 am
However, evidence of SARS-CoV-2 replication in the central nervous system (CNS), sickness behavior ... which cannot be ascertained by self-reported data analyzed in previous studies.
- Drug Found To Stop Nervous System Tumor Growthon June 21, 2022 at 9:06 pm
Researchers discover that in the NF1 cancer predisposition syndrome, hyperactive neurons drive tumor growth Neurofibromatosis type 1 (NF1) patients develop tumors on nerves throughout their bodies.
- ALS may be linked to both the immune and central nervous systemson June 21, 2022 at 5:00 pm
The immune system may play a fundamental role along with the central nervous system in amyotrophic lateral sclerosis (ALS), also known as 'Lou Gehrig's disease,' researchers report.
via Bing News